B

Bristol Myers Squibb

Makes drugs for cancer, blood and immune diseases

Executive Director - Global Medical Oncology, Medical Product Lead

Biology & BiotechUpdated on Nov 11
Full-timeHybrid

About the Job

Requirements

  • An advanced degree in medicine, science, or a related field; an MD is preferred.
  • At least 15 years of medical affairs, development, or commercial experience, with a strong track record in international markets.
  • Pharmaceutical experience in solid tumors, including breast, thoracic, gastrointestinal, and genitourinary cancers.
  • Experience leading large, geographically distributed teams and driving high performance in competitive environments.
  • Deep understanding of regulatory, healthcare, and cultural diversity across international markets.
  • Demonstrated ability to execute strategies that deliver measurable business and patient outcomes.
  • Ability to collaborate effectively across research and development, disease management, marketing, and external development, and to build strong external relationships.
  • Outstanding project management capabilities and experience in change management, leading teams through market or organizational transformation.
  • Ability to provide a strong voice to the global team and effectively communicate with and influence senior leadership and matrix teams.

Responsibilities

  • Develop and execute a unified global medical strategy for Izabren across tumor types and lines of therapy, aligned with global and U.S. strategy.
  • Lead and manage the dedicated medical Izabren teams at Global and U.S. levels, aligning messaging, evidence, and education across the enterprise.
  • Drive rapid decision-making and execution, removing delays inherent in traditional matrix models.
  • Ensure direct accountability at international, regional, and field levels, enabling real-time progress tracking and immediate intervention.
  • Optimize trial execution and site engagement across markets for the global Izabren program, including Phase 2/3 and Phase 3 studies in breast, lung, and urothelial cancers, in collaboration with RCO and the International Izabren Lead.
  • Monitor the competitive landscape, including other EGFR-, HER3-, and TROP2-directed antibody-drug conjugates, bispecifics, and standard-of-care chemotherapy, and adapt strategies to maintain leadership.
  • Oversee resource allocation, budget management, and strategic prioritization.
  • Establish and monitor key performance indicators, dashboards, and reporting tools for continuous improvement.
  • Partner with Clinical Development, Safety, Translational/Biomarker, and Regulatory teams to ensure medical insights and real-world evidence needs inform the Izabren development plan and future label.
  • Collaborate with the Alliance Lead and SystImmune counterparts to ensure joint medical and scientific alignment across territories.
  • Build and empower a high-performing, dedicated team of regional Izabren leads and dedicated medical science liaisons, fostering scientific advocacy and accelerating site activation, recruitment, and medical education on antibody-drug-conjugate topics such as toxicity management, dose optimization, and biomarker strategy.
  • Shape external perception and scientific leadership by leveraging early signal detection and rapid course correction; engage key opinion leaders, investigators, and professional societies; and plan data dissemination at key congresses.
  • Partner with Global Medical, Development, Commercial, Market Access, and Patient Advocacy teams to ensure pre-launch excellence and maximize portfolio value.
  • Represent Izabren in key stakeholder and partnership meetings, including joint governance with SystImmune, and drive cross-functional alignment and enterprise initiatives.

Desired Qualifications

  • Experience with antibody-drug conjugates, bispecific antibodies, and/or Phase 3 oncology development.

About the Company

Bristol Myers Squibb

Makes drugs for cancer, blood and immune diseases

Bristol Myers Squibb discovers, develops and sells prescription medicines for serious illnesses, including cancer, blood disorders, immune diseases and heart disease, for patients treated by doctors and hospitals around the world. Its best-known drug is Opdivo, an immunotherapy that helps the body's own immune system find and attack many kinds of cancer. Researchers develop drug candidates in its labs or bring them in through acquisitions and partnerships, then test them in clinical trials to win regulatory approval. The company makes and markets the approved medicines and earns its revenue from sales of patent-protected drugs. Its roots go back to a business founded in 1887, and it is based in Lawrence Township, New Jersey.

Company size
10,001+
Company stage
IPO
Headquarters
Lawrence Township, NJ
Founded
1887

Recently Posted Jobs

Explore more opportunities at Bristol Myers Squibb

See more jobs